We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Align Technology (ALGN - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Align Technology is one of 925 companies in the Medical group. The Medical group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Align Technology is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ALGN's full-year earnings has moved 3.2% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, ALGN has gained about 21.7% so far this year. In comparison, Medical companies have returned an average of 1.6%. This means that Align Technology is performing better than its sector in terms of year-to-date returns.
Another stock in the Medical sector, Bayer Aktiengesellschaft (BAYRY - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 18.4%.
Over the past three months, Bayer Aktiengesellschaft's consensus EPS estimate for the current year has increased 9.5%. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, Align Technology is a member of the Medical - Dental Supplies industry, which includes 15 individual companies and currently sits at #80 in the Zacks Industry Rank. Stocks in this group have gained about 6.7% so far this year, so ALGN is performing better this group in terms of year-to-date returns.
On the other hand, Bayer Aktiengesellschaft belongs to the Large Cap Pharmaceuticals industry. This 11-stock industry is currently ranked #161. The industry has moved +3.5% year to date.
Investors interested in the Medical sector may want to keep a close eye on Align Technology and Bayer Aktiengesellschaft as they attempt to continue their solid performance.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Align Technology (ALGN - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Align Technology is one of 925 companies in the Medical group. The Medical group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Align Technology is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ALGN's full-year earnings has moved 3.2% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, ALGN has gained about 21.7% so far this year. In comparison, Medical companies have returned an average of 1.6%. This means that Align Technology is performing better than its sector in terms of year-to-date returns.
Another stock in the Medical sector, Bayer Aktiengesellschaft (BAYRY - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 18.4%.
Over the past three months, Bayer Aktiengesellschaft's consensus EPS estimate for the current year has increased 9.5%. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, Align Technology is a member of the Medical - Dental Supplies industry, which includes 15 individual companies and currently sits at #80 in the Zacks Industry Rank. Stocks in this group have gained about 6.7% so far this year, so ALGN is performing better this group in terms of year-to-date returns.
On the other hand, Bayer Aktiengesellschaft belongs to the Large Cap Pharmaceuticals industry. This 11-stock industry is currently ranked #161. The industry has moved +3.5% year to date.
Investors interested in the Medical sector may want to keep a close eye on Align Technology and Bayer Aktiengesellschaft as they attempt to continue their solid performance.